Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 141-150 of 3233

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Clinical Trial To Evaluate Efficacy And Safety Of Xeomin® Injections For Preventing Episodic Migraine

    Rochester, MN

  2. Study To Evaluate Resmetirom In Post-Liver Transplant Patients With MASH

    Rochester, MN

  3. ACT Trial

    Eau Claire, WI, La Crosse, WI, Mankato, MN, Rochester, MN

  4. VenusP-Valve Pivotal Study (PROTEUS STUDY)

    Rochester, MN

  5. ALLIANCE AVIV: Safety And Effectiveness Of The SAPIEN X4 Transcatheter Heart Valve In Failing Aortic Bioprosthetic Valves

    Rochester, MN

  6. [Trial Of Device That Is Not Approved Or Cleared By The U.S. FDA]

    Rochester, MN

  7. Arm Elevation For Prevention Of Propofol Injection Pain

    Jacksonville, FL

  8. A Study To Learn About The Effects Of Felzartamab Infusions In Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation

    Rochester, MN

  9. A Study Comparing Higher Dose Chemotherapy Over A Shorter Amount Of Time To Lower Dose Chemotherapy Plus Maintenance Over A Longer Amount Of Time In Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

    Rochester, MN

  10. A Study Of MACI In Patients Aged 17 To 65 Years With Symptomatic Chondral Or Osteochondral Defects Of The Ankle

    Rochester, MN

.

Mayo Clinic Footer